Natixis Advisors LLC Has $17.65 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Natixis Advisors LLC reduced its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 12.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 183,990 shares of the company's stock after selling 25,185 shares during the period. Natixis Advisors LLC owned about 0.21% of HealthEquity worth $17,654,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Madison Investment Advisors LLC purchased a new stake in shares of HealthEquity in the fourth quarter worth approximately $6,731,000. Skandinaviska Enskilda Banken AB publ increased its stake in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after buying an additional 445 shares during the period. Swiss National Bank lifted its position in HealthEquity by 1.1% in the 4th quarter. Swiss National Bank now owns 171,700 shares of the company's stock worth $16,475,000 after buying an additional 1,800 shares in the last quarter. Avantax Advisory Services Inc. lifted its position in HealthEquity by 23.4% in the 4th quarter. Avantax Advisory Services Inc. now owns 9,645 shares of the company's stock worth $925,000 after buying an additional 1,827 shares in the last quarter. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of HealthEquity by 7.9% during the 4th quarter. Sequoia Financial Advisors LLC now owns 14,364 shares of the company's stock valued at $1,378,000 after buying an additional 1,050 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

HQY has been the topic of a number of research reports. JMP Securities upped their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Raymond James raised their price target on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 25th. Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target for the company. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday, March 14th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, HealthEquity has a consensus rating of "Moderate Buy" and a consensus price target of $112.92.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.20% of the company's stock.

HealthEquity Price Performance

Shares of HealthEquity stock traded up $0.28 during mid-day trading on Friday, reaching $84.88. 1,740,588 shares of the stock were exchanged, compared to its average volume of 693,710. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $7.36 billion, a price-to-earnings ratio of 77.87, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The firm has a 50-day simple moving average of $104.90 and a 200 day simple moving average of $95.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.